June 26, 2019
Media contact: National Consumers League – Carol McKay, email@example.com, (412) 945-3242 or Taun Sterling, firstname.lastname@example.org, (202) 207-2832
Washington, DC—The National Consumers League (NCL) presented testimony at the Centers for Disease Control’s (CDC) vaccine committee today in Atlanta, GA in support of keeping an important vaccine to prevent pneumococcal disease on the schedule of recommended vaccines.
“We commend the Advisory Committee on Immunization Practices (ACIP)’s 2014 recommendation for coverage of the pneumococcal vaccine. However, we are disappointed with ACIP’s decision today that the vaccine should be administered ‘based on shared clinical decision-making’ in adults 65 years or older who do not have an immunocompromising condition. We think that ACIP’s failing to positively recommend the vaccine is a disservice to patients and is confusing to healthcare providers who administer these vaccines.”
Nearly one million adult cases of pneumococcal disease are reported in the U.S. each year, resulting in 400,000 hospitalizations. Even in this era of multiple treatment modalities, five to seven percent of those hospitalized will die, and a large percentage of them will be seniors.
“We should strive to keep adult immunizations simple and accessible to ensure increased protection. This decision by the committee could negatively impact the perceived importance of vaccines and could compromise vaccine uptake, in turn posing a greater risk of infection amongst older Americans and those they come into contact with.”
NCL will continue to educate consumers about the importance of vaccines in protecting the public health and work to dispel the myths about the safety of vaccines.
About the National Consumers League
The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.